Focusing COVID-19-associated mucormycosis: a major threat to immunocompromised COVID-19

COVID-19 disease has been identified to cause remarkable increase of mucormycosis infection cases in India, with the majority of cases being observed in individuals recovering from COVID-19. Mucormycosis has emanated as an outcome of the recent COVID-19 pandemic outbreak as rapidly developing fatal...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Neelam, Wani, Shahid Nazir, Behl, Tapan, Singh, Sukhbir, Zahoor, Ishrat, Sehgal, Aayush, Bhatia, Saurabh, Al-Harrasi, Ahmed, Aleya, Lotfi, Bungau, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713750/
https://www.ncbi.nlm.nih.gov/pubmed/36454526
http://dx.doi.org/10.1007/s11356-022-24032-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713750/
https://www.ncbi.nlm.nih.gov/pubmed/36454526
http://dx.doi.org/10.1007/s11356-022-24032-2

Ejemplares similares